147 related articles for article (PubMed ID: 36645194)
1. Long-term risk of cancer among the first-degree relatives of epithelial ovarian cancer patients: A cohort study with 48 years of follow up.
Kotaniemi-Talonen L; Pukkala E; Aittomäki K; Auranen A
Acta Obstet Gynecol Scand; 2023 Mar; 102(3):240-245. PubMed ID: 36645194
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.
Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA
Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants.
Jervis S; Song H; Lee A; Dicks E; Tyrer J; Harrington P; Easton DF; Jacobs IJ; Pharoah PP; Antoniou AC
J Med Genet; 2014 Feb; 51(2):108-13. PubMed ID: 24277755
[TBL] [Abstract][Full Text] [Related]
6. The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.
Skasko E; Paszko Z; Niwińska A; Kwiatkowska E; Kruczek A; Pieńkowski T
Eur J Gynaecol Oncol; 2004; 25(4):470-4. PubMed ID: 15285306
[TBL] [Abstract][Full Text] [Related]
7. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of germline pathogenic
Morgan RD; Burghel GJ; Flaum N; Bulman M; Clamp AR; Hasan J; Mitchell CL; Schlecht H; Woodward ER; Lallo FI; Crosbie EJ; Edmondson RJ; Wallace AJ; Jayson GC; Evans DGR
J Med Genet; 2019 May; 56(5):301-307. PubMed ID: 30683677
[TBL] [Abstract][Full Text] [Related]
9. Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study.
Barnard ME; Meeks H; Jarboe EA; Albro J; Camp NJ; Doherty JA
J Med Genet; 2023 Feb; 60(2):119-127. PubMed ID: 35534206
[TBL] [Abstract][Full Text] [Related]
10. The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.
Stratton JF; Thompson D; Bobrow L; Dalal N; Gore M; Bishop DT; Scott I; Evans G; Daly P; Easton DF; Ponder BA
Am J Hum Genet; 1999 Dec; 65(6):1725-32. PubMed ID: 10577927
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
[TBL] [Abstract][Full Text] [Related]
12. Uptake of testing for germline
Stearnes G; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Cohen PA
Int J Gynecol Cancer; 2019 Jul; 29(6):1038-1042. PubMed ID: 31101686
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
[TBL] [Abstract][Full Text] [Related]
14. Cancer incidence in the first-degree relatives of ovarian cancer patients.
Auranen A; Pukkala E; Mäkinen J; Sankila R; Grénman S; Salmi T
Br J Cancer; 1996 Jul; 74(2):280-4. PubMed ID: 8688336
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
Moslehi R; Chu W; Karlan B; Fishman D; Risch H; Fields A; Smotkin D; Ben-David Y; Rosenblatt J; Russo D; Schwartz P; Tung N; Warner E; Rosen B; Friedman J; Brunet JS; Narod SA
Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756
[TBL] [Abstract][Full Text] [Related]
16. Population-based cohort investigations of the risk for malignant tumors in first-degree relatives and wives of men with breast cancer.
Olsson H; Andersson H; Johansson O; Möller TR; Kristoffersson U; Wenngren E
Cancer; 1993 Feb; 71(4):1273-8. PubMed ID: 8435804
[TBL] [Abstract][Full Text] [Related]
17. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Antoniou A; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF
Am J Hum Genet; 2003 May; 72(5):1117-30. PubMed ID: 12677558
[TBL] [Abstract][Full Text] [Related]
18. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.
Simchoni S; Friedman E; Kaufman B; Gershoni-Baruch R; Orr-Urtreger A; Kedar-Barnes I; Shiri-Sverdlov R; Dagan E; Tsabari S; Shohat M; Catane R; King MC; Lahad A; Levy-Lahad E
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3770-4. PubMed ID: 16537453
[TBL] [Abstract][Full Text] [Related]
19. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R
Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
